Orbimed Advisors LLC Adaptive Biotechnologies Corp Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
202Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$180 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$86.4 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$70 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$69.6 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$63.8 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $857M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...